Log In
Print
BCIQ
Print
Print this Print this
 

Foretinib (1363089) (GSK1363089) (formerly XL880)

  Manage Alerts
Collapse Summary General Information
Company Exelixis Inc.
DescriptionInhibitor of c-MET and VEGFR-2
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2) ; c-Met receptor tyrosine kinase
Mechanism of ActionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) kinase inhibitor; Binds Met receptor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today